These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 36180175)
1. Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology. Romero R; Jung E; Chaiworapongsa T; Erez O; Gudicha DW; Kim YM; Kim JS; Kim B; Kusanovic JP; Gotsch F; Taran AB; Yoon BH; Hassan SS; Hsu CD; Chaemsaithong P; Gomez-Lopez N; Yeo L; Kim CJ; Tarca AL Am J Obstet Gynecol; 2022 Oct; 227(4):615.e1-615.e25. PubMed ID: 36180175 [TBL] [Abstract][Full Text] [Related]
2. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. Korzeniewski SJ; Romero R; Chaiworapongsa T; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L Am J Obstet Gynecol; 2016 May; 214(5):629.e1-629.e17. PubMed ID: 26688491 [TBL] [Abstract][Full Text] [Related]
3. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio). Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482 [TBL] [Abstract][Full Text] [Related]
4. Angiogenic imbalance in pregnancies with preterm prelabor rupture of membranes between 34 and 37 weeks of gestation. Kacerovsky M; Hornychova H; Jaiman S; Pavlikova L; Holeckova M; Jacobsson B; Tsiartas P; Musilova I Acta Obstet Gynecol Scand; 2024 Jun; 103(6):1120-1131. PubMed ID: 38511515 [TBL] [Abstract][Full Text] [Related]
5. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia. Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800 [TBL] [Abstract][Full Text] [Related]
6. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962 [TBL] [Abstract][Full Text] [Related]
7. Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing. Espinoza J; Calsavara VF; Kilpatrick S; Rana S; Costantine MM; Boggess K; Wylie BJ; Moore Simas TA; Louis JM; Gaw SL; Murtha A; Wiegand S; Gollin Y; Singh D; Silver RM; Durie DE; Panda B; Norwitz ER; Burd I; Plunkett B; Scott RK; Lemoine E; Thadhani R; Karumanchi SA Am J Obstet Gynecol; 2024 Sep; 231(3):363.e1-363.e11. PubMed ID: 38825028 [TBL] [Abstract][Full Text] [Related]
8. Alterations in maternal sFlt-1 and PlGF: Time to labor onset in term-/late-term pregnancies with and without placental dysfunction. Mitlid-Mork B; Bowe S; Staff AC; Sugulle M Pregnancy Hypertens; 2022 Dec; 30():148-153. PubMed ID: 36228400 [TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241 [TBL] [Abstract][Full Text] [Related]
10. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome. Stepan H; Hund M; Andraczek T Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058 [TBL] [Abstract][Full Text] [Related]
11. Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. Chaiworapongsa T; Romero R; Gotsch F; Suksai M; Gallo DM; Jung E; Krieger A; Chaemsaithong P; Erez O; Tarca AL Am J Obstet Gynecol; 2023 May; 228(5):569.e1-569.e24. PubMed ID: 36336082 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia. Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758 [TBL] [Abstract][Full Text] [Related]
13. Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of Pregnancy. Nan MN; García-Osuna Á; Mora J; Trilla C; Antonijuan A; Orantes V; Cruz-Lemini M; Blanco-Vaca F; Llurba E Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238997 [TBL] [Abstract][Full Text] [Related]
14. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience. Müller A; Horvat V; Vulin M; Mandić S; Šerić V; Vidosavljević D Med Glas (Zenica); 2019 Feb; 16(1):53-59. PubMed ID: 30680983 [TBL] [Abstract][Full Text] [Related]
15. Disorders of placental villous maturation are present in one-third of cases with spontaneous preterm labor. Jaiman S; Romero R; Pacora P; Erez O; Jung E; Tarca AL; Bhatti G; Yeo L; Kim YM; Kim CJ; Kim JS; Qureshi F; Jacques SM; Gomez-Lopez N; Hsu CD J Perinat Med; 2021 May; 49(4):412-430. PubMed ID: 33554577 [TBL] [Abstract][Full Text] [Related]
16. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study. MacDonald TM; Tran C; Kaitu'u-Lino TJ; Brennecke SP; Hiscock RJ; Hui L; Dane KM; Middleton AL; Cannon P; Walker SP; Tong S BMC Pregnancy Childbirth; 2018 Aug; 18(1):354. PubMed ID: 30170567 [TBL] [Abstract][Full Text] [Related]
17. Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth. Sovio U; Gaccioli F; Cook E; Charnock-Jones DS; Smith GCS Am J Obstet Gynecol; 2023 Aug; 229(2):164.e1-164.e18. PubMed ID: 36758709 [TBL] [Abstract][Full Text] [Related]
19. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction. Vatten LJ; Åsvold BO; Eskild A Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089 [TBL] [Abstract][Full Text] [Related]
20. Angiogenic imbalance in pre-eclampsia and fetal growth restriction: enhanced soluble fms-like tyrosine kinase-1 binding or diminished production of placental growth factor? Kluivers ACM; Biesbroek A; Visser W; Saleh L; Russcher H; Danser AHJ; Neuman RI Ultrasound Obstet Gynecol; 2023 Apr; 61(4):466-473. PubMed ID: 36191149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]